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Inflammation and Oxidative Stress
through Human T Lymphocytes




Approximately 65% of patients with T2DM die as a result of cardiovascular
disease with hyperglycemia and hyperlipidemia being important risk factors for
cardiovascular diseases. Both T2DM and atherosclerosis are considered to be inflam-
matory processes Human T-lymphocytes (T-cells) and aortic endothelial cells
(HAEC) have been shown to be components of plaque formation in atherosclerosis. T
cells and HAEC are unique in that in their naive state they have no insulin receptors
responsive to insulin but become activated in vitro hyperglycemia and in vivo hyper-
glycemic conditions such as diabetic ketoacidosis and non-ketotic hyperglycemic
conditions. Our studies show that T-cells and HAEC in the presence of high concen-
trations of glucose /and or the saturated fatty acid (SFA) palmitic acid become
activated and express insulin receptors, reactive oxygen species (ROS), cytokine
elevation, and lipid peroxidation in a time and concentration-dependent manner.
Whereas, the unsaturated fatty acid α-linoleic, was not able to activate these cells and
had a salutary effect on the activation by glucose and palmitic acid. We have demon-
strated that unsaturated fatty acids (UFA) may provide a protective mechanism
against the prooxidant effects of hyperglycemia and high SFA such as palmitic acid.
Therefore, diet alternations may be beneficial for decreasing hyperglycemia and
cardiovascular risks. Studies have shown that lifestyle changes of diet and exercise
can reduce the risk of developing diabetes by 58%. Hyperglycemia and hyperlipid-
emia are important risk factors of developing diabetes and cardiovascular disease.
Therefore, we studied the effects of a High Protein diet versus a High Carbohydrate
diet in obese non-diabetic, prediabetic and diabetic subjects for effects on weight loss,
blood sugar, lipid levels, inflammation, and oxidative stress.
Keywords: blood glucose, free fatty acids, insulin sensitivity, inflammation,
cardiovascular risk factors, T lymphocytes, human aortic endothelial cells (HAEC),
high protein diet (HP), high carbohydrate diet (HC)
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1. Introduction
Greater than 65% of patients with Type 2 Diabetes Mellitus (T2DM) die as a
result of cardiovascular disease with hyperglycemia and hyperlipidemia being
important risk factors for cardiovascular diseases [1]. Studies have shown that
glucose control results in reduction in risk of microvascular complications in diabe-
tes mellitus [2]. The relationship between hyperglycemia and macrovascular com-
plications, however, is not as evident even though subjects with T2DM are two to
four times more prone to develop cardiovascular pathology than nondiabetic sub-
jects [3, 4]. Hyperglycemia is a crucial factor contributing to vascular impairment in
diabetes mellitus, obesity, and metabolic syndrome [2, 5–7]. Evidence indicates that
in hyperglycemic conditions a major contributor to development of large vessel
pathology is the endothelial dysfunction [8–10]. Studies have shown that hypergly-
cemia impairs insulin induced vasodilatory action by decreasing endothelial cells
ability to activate nitric oxide synthase-nitric oxide pathway [11]. In hyperglycemic
crisis of Diabetic Ketoacidosis (DKA) or hyperglycemic nonketotic state, where
both hyperglycemia and high fatty acids are elevated, levels of proinflammatory
cytokines and oxidative stress are stimulated [12].
Both T2DM and atherosclerosis are considered to be inflammatory processes
[13]. Human T-lymphocytes (T-cells) have been shown to be components of plaque
formation along with endothelial cells in atherosclerosis [13]. Human T-
lymphocytes have unique properties in that in their naïve state they are insulin
unresponsive but upon exposure to high glucose levels they become activated and
develop insulin receptors (INR) with emergence of insulin degrading enzyme and
insulin responsive glucose uptake [14–19]. Our studies have shown that reactive
oxygen species (ROS) along with proinflammatory cytokines such as: Tumor
Necrosis Factor α (TNF-α), Interleukin-6 (IL-6), Interleukin-1β (IL-1β) and Inter-
leukin-8 (IL-8); cardiovascular risk markers such as: PAI-1, CRP and Free Fatty
Acids (FFA); and counterregulatory hormones such as: IGF-1 and cortisol were all
elevated two to three fold above normal with hyperglycemia and returned to nor-
mal levels after resolution of hyperglycemia with treatment with insulin and
hydration [12]. Our studies have also shown in vitro effects of hyperglycemia (15
and 30 mM) on activation of T-lymphocytes by emergence of IGF-1, INR and
Vitamin D receptors and increased levels of ROS and lipid peroxidation [15–18, 20].
Human aortic endothelial cells (HAEC) are also unique in that in their native
unstimulated state of glucose of 5 mM they are insulin non-responsive, with GLUT1
as the major glucose transporting protein [21–23]; however, in the presence of high
glucose concentrations in a dose dependent manner such as 15 or 30 mM, develop
INR and GLUT 4 with glucose uptake [24]. Additionally, high glucose promotes
endothelial dysfunction via excessive intracellular glucose accumulation and oxida-
tive stress, leading to increased production proinflammatory cytokines, ROS with
induction of the aldose reductase pathway and formation of advanced glycation end
products (AGEs) as well as enhanced signaling of protein kinase C (PKC) and
mitogen-activated protein kinases (MAPK) [8, 25]. The ROS causes acceleration of
cellular growth and promotes synthesis and secretion of proinflammatory cytokines
IL-6 and IL-8 which are implicated in the pathogenesis of atherosclerosis [24, 26, 27].
2. Inflammation and oxidative stress effects of glucose and fatty acids
on human T-lymphocytes and HAEC
Since both hyperglycemia and hyperlipidemia are important contributing risk
for cardiovascular events in diabetes and deleterious effects of hyperglycemia have
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been well documented in vivo and in vitro in both T-lymphocytes and HAEC
[12, 15, 17, 19, 20, 28–30], we studied the effects of various fatty acids on these cells.
The saturated fatty acid palmitic acid, the major fatty acid in plasma, and the
monounsaturated, oleic (C18:1), polyunsaturated fatty acids, linoleic (C18:2),
omega 3 fatty acid α-linolenic (C18:3), and arachidonic (C20:4) acids were used in
1, 100 and 300 uM concentrations during incubations for 0, 24, 48, 72 and 96 hours.
These cells were incubated alone or with glucose concentrations of 5 mM, 15 mM
and 30 mM or with a combination with linolenic acid. Unsaturated fatty acids such
as linoleic, oleic, linolenic, and arachidonic acids were not able to activate these
cells. These studies showed that palmitic acid, but not oleic, linoleic, linolenic or
arachidonic acids, exhibited dose and time dependent responses of deleterious
effects of palmitic acid by demonstrating increased levels of ROS and lipid peroxi-
dation (malondialdehyde- MDA), emergence of receptors for insulin, IGF-1, IL-2,
GLUT 4, inflammatory and proinflammatory effects detected by the emergence of
interleukin (IL) cytokines IL-1B, IL-6, IL-8, IL-2, IL-10, and TNFα. and CD69 in T
lymphocytes [31]. There was also increased expression of E-selectin, GLUT 4, INR,
ROS, lipid peroxidation, inflammatory and proinflammatory effects detected by the
emergence of interleukin (IL) cytokines IL-1B, IL-6, IL-8, IL-2, IL-10, and TNFα in
the HAEC incubated with palmitic acid and/or glucose. Table 1 shows the effects of
the glucose, palmitic and linolenic incubated alone or in combination with the T
lymphocytes. The omega 3 fatty acid linolenic acid had a repressive effect on the
deleterious effects of the high glucose and palmitic acid. Table 2 shows the effects
of the glucose, palmitic and linolenic incubated alone or in combination with the
HAEC. The omega 3 fatty acid linolenic acid had a repressive effect on the deleteri-
ous effects of the high glucose and palmitic acid in the HAEC as well.
Studies have shown that dietary SFA can induce insulin resistance [32–35]. We
hypothesized that unsaturated fatty acids (UFA) may provide a protective mecha-
nism against the prooxidant effects of hyperglycemia and high SFA such as palmitic
acid. Our studies have also shown that SFA palmitic acid induces expression of
GPR40 and FATCD/36 involved in inflammation and the unsaturated fatty acid
linolenic acid can reverse the production of these receptors in aortic endothelial
cells [36].
Thus, linolenic acid may serve as a protective mechanism against the deleterious
effects of high glucose and palmitate in human T-cells and HAEC and reduce the
inflammatory process observed with high blood glucose and high saturated fatty
acid foods as observed in diabetes, prediabetes, cardiovascular disease and other
health conditions.
3. High protein and high carbohydrate diets effects on remission of
prediabetes, inflammation, oxidative stress and cardiovascular
risk factors
Lifestyle changes of diet and exercise can reduce the risk of developing diabetes
by 58% [37]; whereas, pharmaceutical intervention reduces the risk by 32% (met-
formin) [37] and 72% (pioglitazone) [38]. Hyperglycemia and hyperlipidemia are
important risk factors of developing diabetes and cardiovascular disease; however,
no diet had been established for reducing the hyperglycemia and hyperlipidemia.
Although numerous diets have been recommended for T2DM and non-diabetics
[39–43], and suggested advantages of low-carbohydrate [44, 45] or high protein
[46, 47] diets, there had been no consensus on a specific weight loss diet to manage
blood glucose in T2DM and converting from T2DM to normal glucose tolerance. We
studied the effects of macronutrients in a High Protein (HP) (30% Kcal protein,
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Glucose (G) Palmitic acid (P) Linolenic acid (L) G (15 mM) + P
(100 μM)
G (15 mM) + L
(100 μM)
G (15 mM) + P (100 μM) + L
(100 μM)
5 mM 15 mM 30 mM 5 μM 100 μM 300 μM 5 μM 100 μM 300 μM
Activation markers
CD69 (%) <1 11  .7* 26  3* <1 2  1* 3  .8* <1 <1 <1 14  2† 4  .6† 6  1.7∆
INSR (%) 0 5  1* 12  2* 0 8  2* 14  2* 0 0 0 12  2† 2  .6† 5  2∆
CD25 (%) 0 6  1* 17  3* 0 10  2* 18  3* 0 0 0 15  3† 3  .5† 6.5  .4∆
Oxidative stress
DCF (%) 0 7  1.2* 23  2* 1  .3 14  2* 30  3* 0 0 0 21  3† 4  .5† 8  2∆
TBA (MDA) 0 6  2* 19  4* .8  .1 10  2* 22  3* 0 0 0 15  2† 3 + 1† 9  1∆
Inflammation
TNFα (pg/ml) 7  1 36  2* 185  4* 7  1 71  3* 98  3* 7  2 8  3 7  2 94  4† 15  2† 49  3∆
IL-1β (pg/ml) 3  1 18  * 51  2* 3  1 21  2* 34  2* 3  1 4  1 3  1 29  3† 11  1† 17  2∆
IL-6 (pg/ml) 6  1 43  2* 171  3* 6  2 58  3* 87  3* 6  2 7  2 6  2 128  4† 27  3† 71  3∆
IL-8 (pg/ml) 12  2 184  3* 215  5* 10  2 78  3* 102  4* 9  2 9  2 9  2 235  6† 83  3† 118  3∆
IL-2 (pg/ml) 23  2 69  3* 172  4* 23  3 87  4* 119  3* 23  2 24  3 23  2 153  4† 36  3† 89  2∆
IL-10 (pg/ml) 9  1 20  2* 69  3* 9  2 34  3* 58  3* 9  2 9  2 9  2 47  3† 12  1† 29  3∆
Inflammation inhibition with NFkBi
TNFα + NFkBi 6  1 6  1 6  2 5  1 5  2 6  2 5  1 5  1 5  1 7  2 7  2 7  3
Values indicate mean  SE. Measured at 72 hours.
*P < 0.05 from baseline.
†p < 0.05 from glucose (15 mM) or palmitate (100 uM).
∆p < 0.05 from glucose (15 mM) + palmitate (100 uM).
Table 1.


































Glucose (G) Palmitic Acid (P) Linolenic Acid (L) G (15 mM) + P
(100 μM)
G (15 mM) + L
(100 μM)
G (15 mM) + P
(100 μM) + L (100 μM)
5 mM 15 mM 30 mM 5 μM 100 μM 300 μM 5 μM 100 μM 300 μM
E-Selectin% <1 24  4* 39  3† <1 18  3* 42  4† <1 <1 <1 39  7† 11  3† 15  4∆
INSR (%) <1 25  3* 37  3† <1 8  2* 22  3† <1 <1 <1 30  3† 8  2† 12  2∆
IGF-IR % <1 8  2* 20  2† <1 10  3* 24  3† <1 <1 <1 16  3† 4  1† 5  2∆
GLUT 4% <1 17  3* 34  3† <1 3  1* 8  2† <1 <1 <1 22  3† 6  2† 7  2∆
GLUT 1% 3  1 19  3* 30  3† 3  1 6  2* 13  3† 3  1 3  2 3  2 21  3† 8  2† 9  2∆
IRS-1% 0 15  3* 34  3† 0 7  2* 11  2† 0 0 0 17  3† 6  2† 8  2∆
Oxidative stress
DCF (%) 0 9  1* 26  2† 0 14  2* 34  4† 0 0 0 22  3† 4  .5† 7  2∆
MDA (μM) 0 7  2* 20  4† 0 12  2* 29  4† 0 0 0 17  2† 3 + 1† 8  1∆
Inflammatory markers
TNFα (pg/ml) 18  1 39  2* 172  4†^ 18  2 23  4* 137  5† 18  2 18  3 19  2 94  4† 15  2† 49  3∆
IL-1β (pg/ml) 3  1 18  2* 51  2† 2  1 7  2* 10  2† 2  1 3  1 3  1 29  3† 11  1† 17  2∆
IL-6 (pg/ml) 21  3 36  3* 53  4† 19  3 31  4* 66  4† 17  2 18  3 18  2 128  4† 27  3† 71  3∆
IL-8 (pg/ml) 171  1 384  6* 915  7† 170 286  3* 759  9† 167  7 169  9 171  8 335  6† 203  3† 218  3∆
IL-2 (pg/ml) 0 0 0 0 0 0 0 0 0 0 0 0
IL-10 (pg/ml) 2  1 2  1 2  1 2  1 3  1 3  1 2  1 2  1 2  1 2  1 2  1 2  1
Values indicate mean  SE. Measured at 72 hours.
*P < 0.05 from baseline.
†p < 0.05 from glucose (15 mM) or palmitate (100 uM).
∆p < 0.05 from glucose (15 mM) + palmitate (100 uM).
Table 2.
Effect of hyperglycemia (glucose), hyperlipidemia (palmitic acid) on activation of human aortic endothelial cells, inflammation (proinflammatory cytokines and IL-10) and oxidative stress

















































40% Kcal carbohydrate (CHO) and 30% Kcal fat) diet versus a High Carbohydrate
(HC) (15% Kcal protein, 55% Kcal CHO and 30% Kcal fat) diet in obese, normal
glucose tolerance premenopausal women [48] (see Table 3) and in obese predia-
betic (Impaired Glucose Tolerant (IGT)) women and men [49] (see Table 4) in
randomized, controlled clinical trials. In both studies all food was provided with
weekly food pick up with daily menus and weight checks for 6 months. Although
our study of IGT subjects [49] and obese, non-diabetic, women [48] had significant
HP (n = 12) HC (n = 12)
Parameters Baseline 6 months p* Baseline 6 months p* p**




BMI (kg/m2) 41.3  1.8 37.3  1.9 0.0005 37.0  1.5 33.5  1.4 0.0005 0.5512
%Weight loss 9.8  1.4 0.0005 9.3  1.6 0.0005 0.9323
HOMA IR 4.0  0.8 1.4  0.2 0.0005 3.7  0.4 2.3  0.3 0.0005 0.0033
ISI (Matsuda
Index)
2.7  0.5 6.7  0.5 0.0005 2.6  0.3 3.5  0.4 0.0005 <0.0001
Beta cell
function
4.4  0.4 11.8  2.5 0.0005 4.2  0.4 6.3  0.6 0.0005 <0.0001
Cardiovascular risk factors
TG (mg/dl) 107  10 81  2.7 0.0005 102  5.7 94  3.8 0.0117 0.0907
Free fatty
acids (mM)
0.57  0.03 0.45  0.03 0.0010 0.56  0.04 0.73  0.07 0.0342 0.0002
hCRP (mg/L) 5.9  0.2 3.8  0.4 0.0005 5.8  0.2 5.0  0.2 0.0005 0.0003
E-selectin
(ng/ml)




















5.9  1.3 4.1  0.2 0.0005 6.0  0.2 5.1  0.1 0.0005 <0.0001
IL-6 (pg/ml) 6.2  0.2 4.9  0.2 0.0005 5.8  0.2 5.4  0.1 0.0005 <0.0001
Oxidative stress
DCF (μM) 3.2  0.1 2.4  0.1 0.0005 3.2  0.1 2.9  0.1 0.0005 <0.0001
MDA (μM) 1.1  0.06 0.7  0.05 0.0005 1.1  0.05 0.9  0.05 0.0005 0.0004
%
Compliance
94% 1.5% 91%  4.8% 0.3979
Significant level for multiple comparison is set at P = 0.01.
*Indicates Wilcoxon Signed Rank Test.
**Indicates Wilcoxon Rank Sum Test for 6 months HP vs. HC.
†Fisher’s exact test.
AA/C, African American/Caucasian; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure;
TG, triglyceride; hsCRP, high sensitivity C-reactive protein; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6;
DCF, dichlorofluorescein; MDA, malondialdehyde.
Table 3.
Effect of high protein or high carbohydrate diets on weight loss, insulin sensitivity, Beta cell function, markers of
cardiovascular risk factors, inflammation and oxidative stress in obese premenopausal, non-diabetic women.
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weight loss (9–10%) on the HP or HC diets, in both studies the HP diet provided
greater improvement in insulin sensitivity, reduced CVR factors, decreased inflam-
mation and inflammatory cytokines, decreased oxidative stress, decreased lipid
peroxidation, adipokines markers and increased incretin responses [50, 51]. The HP
HP (n = 12) HC (n = 12)
Parameters Baseline 6 months p* Baseline 6 months p* p**
% Remission 100 33.3 0.001
Age 43.1  1.3 41.1  1.7 0.96
Ethnicity AA/C 10/2 9/3
Female/male 9/3 10/2
% Weight loss 9.8  1.4 <0.001 11.3  1.8 <0.001 0.692
BMI (kg/m2) 40.5  1.8 37.3  1.9 <0.001 37.4  1.7 33.8  1.6 0.002 0.391
%
LeanBMchange
2.6  0.4 0.002 3.0  1.1 0.005 0.001
% Fat BM
change
2.5  0.4 0.006 3.5  0.9 0.007 0.04
Insulin sensitivity
HbA1c % 6.0  0.015 5.46  0.12 .0005 5.93  0.12 5.73  0.17 0.005 <0.0001
HOMA IR 4.79  0.71 1.58  0.38 0.0005 4.74  0.72 3.34  0.78 0.005 <0.0001
ISI (Matsuda
index)
2.3  0.3 6.5  1.1 0.0005 2.3  0.3 3.2  0.4 0.005 0.003
Cardiovascular risk factors













TG (mg/dl) 106.9  10 69.4  6.7 0.001 110.1  11 98.7  9.1 0.002 0.04
LDL (mg/dl) 105.9  4.4 82.4  3.4 0.0005 106.2  5.6 101.9  6.2 0.096 0.037
Cholesterol
(mg/dl)
165.3  5.7 151.8  5.3 0.0005 167.9  6.1 161.7  6.3 0.02 0.42
HDL (mg/dl) 44.9  1.7 46.3  1.4 0.10 45.8  2.6 46.2  2.5 0.69 0.85
FFA (mM) 0.74  0.05 0.46  0.04 0.0010 0.74  0.04 0.72  0.05 0.064 0.0001
hCRP (mg/L) 9.1  0.4 4.0  0.3 0.0001 8.8  0.3 6.4  0.2 0.005 0.0003
E-Selectin
(ng/ml)
53.7  1.5 35.0  1.1 0.0005 53.4  1.6 44.6  1.7 0.005 0.0005
Proinflammatory cytokines
TNF-α (pg/ml) 12.8  0.4 3.8  0.2 0.0005 12.5  0.4 9.6  0.3 0.005 <0.0001
IL-6 (pg/ml) 8.57  0.34 4.55  0.13 0.0005 8.43  0.22 6.8  0.11 0.0005 <0.0001
Oxidative stress
DCF (μM) 3.9  0.2 2.5  0.3 0.0004 4.0  0.1 3.2  0.2 0.01 <0.0001
MDA (μM) 1.5  0.07 0.6  0.04 0.0008 1.5  0.08 1.2  0.04 0.02 0.0004
*Indicates Wilcoxon Signed Rank Test for comparison of Baseline to 6 months.
**Indicates Wilcoxon Rank Sum Test for 6 months comparison of HP vs. HC.
Table 4.
Effect of HP or HC diets on remission of prediabetes, weight loss, glucose, insulin sensitivity, cardiovascular risk
factors, proinflammatory cytokines and oxidative stress.
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diet caused a smaller increase in blood glucose with the MTT compared to the HC
diet MTT in both obese, normal glucose tolerance premenopausal women (see
Figure 1) and in obese prediabetic women and men (see Figure 2), thereby,
reducing the hyperglycemia compared to that observed with a HC meal. Lipids are
considered a primary risk factor for CV disease and dietary composition can affect
the lipid profile and its metabolism. Our studies showed greater decrease in tri-
glycerides in the HP diet demonstrating that increasing the protein in the diet may
alter the lipid profile in a beneficial way.
Also, the HP diet subjects had an increase in percent body muscle mass and
decrease in percent fat mass at 6 months, whereas, the HC diet subjects had a
decrease in percent lean and fat mass. Additionally, the HP group had an increase in
their resting metabolic rate (RMR) at 6 months, and an increase in the FGF21 which
may be indicative of browning of fat [52, 53]. Epigenetic DNA methylation data
showed a change in the methylation with remission of prediabetes in the areas of
metabolism, cancer and heart related genes [54, 55].
It has been shown that protein intake by itself induces insulin release and is
different in diabetic and non-diabetic individuals [56]. Our study showed a lower
insulin response to the HP than the HC diet in both studies. This suggests that HP
Figure 1.
Obese premenopausal non-diabetic women mean glucose values for the OGTT and MTT from 0 to 120 minutes
for the baseline-HP, baseline-HC, 6 months-HP, and 6 months-HC diets for the 12 HP subjects and
the 12 HC subjects. P values are the significance of area under the curve for glucose for the OGTT and MTT
comparing baseline-HP with 6 month-HP, baseline-HC with 6 month-HC, baseline-HP with baseline-HC,
and 6 month-HP with 6 month-HC diets.
Figure 2.
This figure shows the mean  SD of glucose for the 2 hour OGTT and MTT for the 12 HP diet subjects and the
12 HC diet subjects. The symbols represent the following: HP diet baseline (HP-Bl) and HP diet at
6 months (HP-6 m) dotted lines. HC diet baseline (HC-Bl) and HC diet at 6 months (HC-6 m) solid
lines. P values for the glucose AUC for the OGTT are: HP-Bl vs. HP-6 m = 0.0005; HC-Bl vs. HC-6 m = 0.005;
HP-Bl vs. HC-Bl = 0.8; HP-6 m vs. HC-6 m = 0.0001. P values for the glucose AUC for the MTT are: HP-Bl vs.
HP-6 m = 0.0005; HC-Bl vs. HC-6 m = 0.005; HP-Bl vs. HC-Bl = 0.01, HP-6 m vs. HC-6 m = 0.0001. AUC,
area under the curve; HP, High Protein diet; HC, High Carbohydrate diet.
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diets may help preserve the Beta cells by increasing sensitivity and decreasing
insulin load per meal. Our studies on the incretin response to HP and HC diets
showed an increased release in GLP-1 and GIP with the HP diet compared to the HC
diet [57]. Treatment of T2DM subjects with GLP-1 receptor agonists and DPP-4
inhibitors have been found to improve insulin sensitivity [58, 59]. This suggests that
our HP diet may be beneficial in treating T2DM and have cardiovascular benefits.
This prompted us to study the effect of the HP and HC diets on remission of
T2DM. Our current randomized clinical trial of Remission of Type 2 Diabetes to
normal glucose tolerance (NGT) comparing a HP diet to a HC diet has demon-
strated a 100% remission of Type 2 Diabetic subjects to normal glucose tolerance
who were diagnosed with the past 2 years and were randomized to the HP diet for
6 months.
However, the HC diet was not very effective with only one subject having
remission to normal glucose tolerance. T2D adults aged 20–65 years were random-
ized to a HP or HC diet for 6 months with all food provided. Caloric need for weight
loss was determined by Resting Metabolic Rate (RMR) -500 calories/day. Oral
Glucose Tolerance Tests (OGTT) were performed at Baseline and 6 months to
determine T2D/NGT status. A Baseline glucose ≥126 mg/dl and HbA1c ≥ 6.5% and
2 hr. glucose >199 mg/dl was considered T2D and remission was a baseline glucose
<126 mg/ml and HbA1c < 6.5% and 2 hr. glucose <140 mg/dl. DXA was done at
baseline and 6 months to determine bone, lean and fat mass. Food pick up and
menus were provided weekly for 6 months along with and weekly weight checks.
The T2D subjects on HP diet had 100% remission to NGT while the HC diet subjects
had 33% remission. Both diet groups had significant weight loss (HP =15.4  5 lb.,
HC = 19.9  5 lb), improvement in insulin sensitivity determined by HOMA IR [HP
(BL 5.3  0.29; 6 months 2.1  0.13)], [HC (BL 5.2  0.27; 6 months 4.4  0.26)]
and decrease in HbA1c [HP (BL 7.7 .05; 6 mo 5.6 .02)], [HC (BL 7.8 .04; 6 mo
6.6  .06)] and blood pressure improvement S/D [HP (BL 129/85, 6 months 117/
78)], [HC (BL 130/85; 6 months 117/78)]. The HP group had a 2.7% 0.4% increase
in lean body mass and 2.9  0.4% decrease in fat mass while the HC group had a
1.9%  0.3 and 3.3  0.9% decrease in lean and fat mass, respectively. The HP diet
provided greater improvement in insulin sensitivity, reduced CVR factors,
decreased inflammation and inflammatory cytokines, decreased oxidative stress,
decreased lipid peroxidation, adipokines markers and increased incretin responses
than the HC diet. Both diets resulted in weight loss, improvement in glucose toler-
ance and insulin sensitivity but only the HP diet produced 100% remission of T2D
to NGT [60].
4. Discussion
High glucose levels initiates inflammatory markers, ROS and hyperglycemia
induced pathways in both T lymphocytes and HAEC. Hyperglycemia induced
pathways of endothelial damage can activate ERK1/2MAPK cascade via PKC or
Advanced Glycation End (AGE) products [4, 25]. High glucose can induce forma-
tion of AGE products which are proteins or lipids which become glycated due to
exposure to glucose. These AGE products are implicated in aging and many degen-
erative diseases such as diabetes, atherosclerosis, kidney disease and possibly
Alzheimer’s disease [61–67]. The glycation of various protein and lipids causes
improper function of these molecules, for example, inactivation of anti-aging genes
critical to prevent hyperglycemia and hyperlipidemia induced inflammation
[68, 69]. We have shown that with remission of prediabetes and better glucose
control numerous genes have changes in DNA methylation affecting gene
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expression and translation of which any of these genes are involved in insulin
signaling, cardiovascular disease and inflammation [55]. The effects of hyperglyce-
mia and hyperlipidemia we have shown on the T-lymphocytes will affect the
immune system and its function as well as the endothelial cells involved in cardio-
vascular function. The decrease in inflammation with the decrease in blood glucose
and lipids in subjects with the HP diet correlates with the effects of glucose and
fatty acids on inflammation and oxidative stress we observed in the in vitro studies
of the T-lymphocytes and aortic endothelial cells. This demonstrates the effects of
the high glucose and lipids on cells and the whole body. Thus, indicating the
importance of good glucose control in diabetic subjects as well as prediabetic and
normal subjects to prevent the inflammatory response. Figure 3 is a diagram of the
effects of high glucose on cells and tissues which can be controlled with normal
glucose and free fatty acids.
Our previous studies of subjects with Adult Respiratory Distress Syndrome
(ARDS) showed the high levels of inflammatory markers. [70, 71]. Reports from
the CDC show the deleterious effects COVID-19 has on diabetic subjects
indicating that the combined inflammation of the virus plus the high
inflammatory markers in diabetic subjects is very detrimental to the subjects. Thus,
good glucose control could help decrease the high inflammatory markers observed
with the COVID-19.
5. Conclusions
Approximately 65% of patients with T2DM die as a result of cardiovascular
disease with hyperglycemia and hyperlipidemia being important risk factors for
cardiovascular diseases. Both Type 2 diabetes (T2DM) and atherosclerosis are con-
sidered to be inflammatory processes. Human T-lymphocytes (T-cells) and Human
Aortic Endothelial cells (HAEC) have been shown to be components of plaque
formation in atherosclerosis. T cells and HAEC are unique in that in their naive state
they have no insulin receptors responsive to insulin but become activated in the
presence of in vitro and in situ hyperglycemic conditions such as diabetic and/or
hyperlipidemia of saturated fatty acids (SFA). The unsaturated fatty acid (UFA) α-
linolenic acid partially inhibits the activation of T cells induced by either glucose or
SFA palmitate alone or in combination. Thus, linolenic acid may serve as a
Figure 3.
This figure shows the relationship and effects of high glucose and lipids (dyslipidemia) on inflammation,
cardiovascular disease, insulin resistance, diabetes mellitus and metabolic syndrome.
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protective mechanism against the deleterious effects of high glucose and SFAs in
human T-cells and reduce the inflammatory process observed with high blood
glucose and high saturated fatty acid foods.
A diet which causes a lower blood glucose and lipids after ingestion is beneficial
in controlling glucose and lipids as we have shown with the High Protein Diet. The
HP diet resulted in 100% remission of pre-diabetes to normal glucose tolerance
while the HC diet resulted in only 33% remission. These results show that high
efficacy can be achieved with dietary modification if parameters are rigorously
controlled and monitored. The HP group had greater improvement in insulin sensi-
tivity, greater reduction in CVR factors, oxidative stress (ROS) and inflammation
than the HC diet group. The HP diet prediabetes group percent lean body mass
(LM) increased while percent body FM was decreased; whereas, the HC diet group
lost both percent LM and FM. Since all subjects were minimally physically active
and there was no physical activity modification during the 6 months on the diets,
we were able to study the direct effect of the HP versus HC diets. The HC group
sustained higher glucose and insulin levels with both the OGTTs and MTTs com-
pared with the HP diet group after 6 months on the diet. The greater insulin
response with the HC diet likely equates to greater stress on β cells. The higher
sustained glucose elevation with ingestion of glucose or higher glycemic foods as in
the HC diet correlates with increased oxidative stress and inflammation in the HC
group compared with the HP group. Antioxidant enzymes induced by repeated
intake of excess energy in the form of high-fat, HC diets are not sufficient to block
oxidative stress and inflammation in healthy human subjects [72]. Thus, the fact
that our HP diet had a significantly greater reduction in blood glucose, free fatty
acids, ROS and inflammation markers than the HC diet in prediabetes and normal




Division of Endocrinology, Diabetes and Metabolism, Department of Medicine,
The University of Tennessee Health Science Center, Memphis, TN, USA
*Address all correspondence to: fstentz@uthsc.edu
©2021 TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
11
Hyperglycemia- and Hyperlipidemia-Induced Inflammation and Oxidative Stress…
DOI: http://dx.doi.org/10.5772/intechopen.94427
References
[1] (CDC) CfDC. National Diabetes
Statistics Report, 2018. wwwcdcgov/
diabetes/data/statistics/
2018StatisticsReport. 2018.
[2]DCCT. The Effect of Intensive
Treatment of Diabetes on the
Development and Progression of Long-
Term Complications in Insulin-
Dependent Diabetes Melllitus. N Engl J
Med. 1993;329(977–86.
[3]Haffner S. Epidemiological Studeis on
the Effects of Hyperglycemia and
Improvement of Glycemic Control on
Macrovascular Events in Type 2 Diabetes.
Diabetes Care. 1999;22(3):C54-C6.
[4] Stern M. Natural History of
Macrovascular Disease in Type 2
Diabetes. Role of Insulin Resistance.
Diabetes Care. 1999;22(3):C2-C5.
[5]Haffner S. Hyperglycemia as a
Cardiovascular Risk Factor. Am J Med.
2003;115(Suppl 8A):6S–11S.
[6] (UKPDS) UPDSG. Intensive Blood-
Glucose Control with Sulphonylureas or
Insulin Compared with Convenional
Treatment, and Risk of Complications in
Patients with Type 2 Diabetes (UKPDS
33). Lancet Diabetes Endocrinol. 1998;352
(837–53.
[7] Kitabchi AE, Umpierrez GE,
Fisher JN, Murphy MB, and Stentz FB.
Thirty years of personal experience in
hyperglycemic crises: diabetic
ketoacidosis and hyperglycemic
hyperosmolar state. J Clin Endocrinol
Metab. 2008;93(5):1541–52.
[8] Creager M. Diabetes and Vascular
DIsease: Pathophysiology, Clinical
Consequences, and Medical Therapy:
Part 1. Circulation. 2003;108(1527–32.
[9]Dandona P, Aljada A, Chaudhuri A,
and Mohanty P. Endothelial
dysfunction, inflammation and diabetes.
Rev Endocr Metab Disord. 2004;5(3):
189–97.
[10]Hink U, Li H, Mollnau H, Oelze M,
Matheis E, Hartmann M, Skatchkov M,
Thaiss F, Stahl RA, Warnholtz A, et al.
Mechanisms underlying endothelial
dysfunction in diabetes mellitus. Circ
Res. 2001;88(2):E14–22.
[11] Schnyder B, Pittet M, Durand J, and
Schnyder-Candrian S. Rapid effects of
glucose on the insulin signaling of
endothelial NO generation and epithelial
Na transport. Am J Physiol Endocrinol
Metab. 2002;282(1):E87–94.
[12] Stentz FB, Umpierrez GE, Cuervo R,
and Kitabchi AE. Proinflammatory
cytokines, markers of cardiovascular
risks, oxidative stress, and lipid
peroxidation in patients with
hyperglycemic crises. Diabetes. 2004;53
(8):2079–86.
[13] Ross R. Atherosclerosis–an
inflammatory disease. N Engl J Med.
1999;340(2):115–26.
[14]Helderman JH. Role of insulin in the
intermediary metabolism of the
activated thymic-derived lymphocyte. J
Clin Invest. 1981;67(6):1636–42.
[15] Stentz FB, and Kitabchi AE. De novo
emergence of growth factor receptors in
activated human CD4+ and CD8+ T
lymphocytes.Metabolism. 2004;53(1):
117–22.
[16] Stentz FB, and Kitabchi AE.
Activated T lymphocytes in Type 2
diabetes: implications from in vitro
studies. Curr Drug Targets. 2003;4(6):
493–503.
[17] Stentz FB, and Kitabchi AE.
Hyperglycemia-induced activation of
human T-lymphocytes with de novo
emergence of insulin receptors and
generation of reactive oxygen species.
12
Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic
Biochem Biophys Res Commun. 2005;335
(2):491–5.
[18] Stentz FB, and Kitabchi AE. Palmitic
acid-induced activation of human T-
lymphocytes and aortic endothelial cells
with production of insulin receptors,
reactive oxygen species, cytokines, and
lipid peroxidation. Biochem Biophys Res
Commun. 2006;346(3):721–6.
[19] Stentz FB, and Kitabchi AE.
Transcriptome and proteome expression
in activated human CD4 and CD8 T-
lymphocytes. Biochem Biophys Res
Commun. 2004;324(2):692–6.
[20] Kitabchi AE, Stentz FB, and
Umpierrez GE. Diabetic ketoacidosis
induces in vivo activation of human
T-lymphocytes. Biochem Biophys Res
Commun. 2004;315(2):404–7.
[21] Bar RS, Boes M, Dake BL, Booth BA,
Henley SA, and Sandra A. Insulin,
insulin-like growth factors, and vascular
endothelium. Am J Med. 1988;85(5A):
59–70.
[22] Chisalita SI, and Arnqvist HJ.
Insulin-like growth factor I receptors are
more abundant than insulin receptors in
human micro- and macrovascular
endothelial cells. Am J Physiol Endocrinol
Metab. 2004;286(6):E896–901.
[23] Kaiser N, Sasson S, Feener EP,
Boukobza-Vardi N, Higashi S,Moller DE,
Davidheiser S, Przybylski RJ, andKingGL.
Differential regulation of glucose
transport and transporters by glucose in
vascular endothelial and smoothmuscle
cells.Diabetes. 1993;42(1):80–9.
[24] Gosmanov AR, Stentz FB, and
Kitabchi AE. De novo emergence of
insulin-stimulated glucose uptake in
human aortic endothelial cells incubated
with high glucose. Am J Physiol
Endocrinol Metab. 2006;290(3):E516–22.
[25] Sheetz MJ, and King GL. Molecular
understanding of hyperglycemia's
adverse effects for diabetic
complications. JAMA. 2002;288(20):
2579–88.
[26] Srinivasan S, Hatley ME, Reilly KB,
Danziger EC, and Hedrick CC.
Modulation of PPARalpha expression
and inflammatory interleukin-6
production by chronic glucose increases
monocyte/endothelial adhesion.
Arterioscler Thromb Vasc Biol. 2004;24
(5):851–7.
[27] Aljada A, Ghanim H, Assian E, and
Dandona P. Tumor necrosis factor-alpha
inhibits insulin-induced increase in
endothelial nitric oxide synthase and
reduces insulin receptor content and
phosphorylation in human aortic
endothelial cells. Metabolism. 2002;51
(4):487–91.
[28] Stentz FB, and Kitabchi AE.
Transcriptome and proteome
expressions involved in insulin
resistance in muscle and activated T-
lymphocytes of patients with type 2
diabetes. Genomics Proteomics
Bioinformatics. 2007;5(3–4):216–35.
[29]Williams SB, Goldfine AB,
Timimi FK, TingHH, RoddyMA,
SimonsonDC, and CreagerMA. Acute
hyperglycemia attenuates endothelium-
dependent vasodilation in humans in vivo.
Circulation. 1998;97(17):1695–701.
[30] Vaidyula VR, Rao AK,Mozzoli M,
HomkoC,CheungP, andBodenG. Effects
of hyperglycemia and hyperinsulinemia
on circulating tissue factor procoagulant
activity and platelet CD40 ligand.
Diabetes. 2006;55(1):202–8.
[31] Stentz FB, Eastman, A., Christman,
J.V. Hyperglycemia and Hyperlipidemia
Induced Inflammation and Oxidative
Stress in Human T Lymphocytes and
Salutary Effects of ω- 3 Fatty Acid.
SunKrist J Diabet Clin Care. 2020;1(1–9.
[32]Grundy SM, and Denke MA. Dietary
influences on serum lipids and
13
Hyperglycemia- and Hyperlipidemia-Induced Inflammation and Oxidative Stress…
DOI: http://dx.doi.org/10.5772/intechopen.94427
lipoproteins. J Lipid Res. 1990;31(7):
1149–72.
[33] RodenM, Price TB, Perseghin G,
Petersen KF, RothmanDL, Cline GW, and
ShulmanGI.Mechanism of free fatty acid-
induced insulin resistance in humans. J
Clin Invest. 1996;97(12):2859–65.
[34] Boden G. Role of fatty acids in the
pathogenesis of insulin resistance and
NIDDM. Diabetes. 1997;46(1):3–10.
[35] Koska J, Ozias MK, Deer J, Kurtz J,
Salbe AD, Harman SM, and Reaven PD.
A human model of dietary saturated
fatty acid induced insulin resistance.
Metabolism. 2016;65(11):1621–8.
[36] Stentz FB. AA, Kitabchi AE. . Effect of
Saturated Fatty Acids andUnsaturated
Fatty Acids on Fatty Acid Receptors and
Transport Proteins in Aortic Endothelial
Cells. J InvestigMed. 2008;56(359.
[37]Diabetes Prevention Program. The
Diabetes Prevention Program (DPP)
Research Group. Reduction in the
incidence of Type 2 Diabetes with
lifestyle intervention or metformin.
NEJM. 2002;346(393–403.
[38]DeFronzo RA, Tripathy D,
Schwenke DC, Banerji M, Bray GA,
Buchanan TA, Clement SC, Henry RR,
Hodis HN, Kitabchi AE, et al.
Pioglitazone for diabetes prevention in
impaired glucose tolerance. N Engl J
Med. 2011;364(12):1104–15.
[39] Franz MJ, Powers MA, Leontos C,
Holzmeister LA, Kulkarni K, Monk A,
Wedel N, and Gradwell E. The evidence
for medical nutrition therapy for type 1
and type 2 diabetes in adults. J Am Diet
Assoc. 2010;110(12):1852–89.
[40] Larsen RN, Mann NJ, Maclean E,
and Shaw JE. The effect of high-protein,
low-carbohydrate diets in the treatment
of type 2 diabetes: a 12 month
randomised controlled trial.
Diabetologia. 2011;54(4):731–40.
[41] Alford BB, Blankenship AC, and
Hagen RD. The effects of variations in
carbohydrate, protein, and fat content
of the diet upon weight loss, blood
values, and nutrient intake of adult
obese women. J Am Diet Assoc. 1990;90
(4):534–40.
[42]McManus K, Antinoro L, and
Sacks F. A randomized controlled trial
of a moderate-fat, low-energy diet
compared with a low fat, low-energy
diet for weight loss in overweight adults.
Int J Obes Relat Metab Disord. 2001;25
(10):1503–11.
[43] Larsen TM, Dalskov SM, van
Baak M, Jebb SA, Papadaki A,
Pfeiffer AF, Martinez JA, Handjieva-
Darlenska T, Kunesova M, Pihlsgard M,
et al. Diets with high or low protein
content and glycemic index for weight-
loss maintenance. N Engl J Med. 2010;
363(22):2102–13.
[44]Nordmann AJ, Nordmann A,
Briel M, Keller U, Yancy WS, Jr.,
Brehm BJ, and Bucher HC. Effects of
low-carbohydrate vs low-fat diets on
weight loss and cardiovascular risk
factors: a meta-analysis of randomized
controlled trials. Arch Intern Med. 2006;
166(3):285–93.
[45] Boden G, Sargrad K, Homko C,
Mozzoli M, and Stein TP. Effect of a
low-carbohydrate diet on appetite,
blood glucose levels, and insulin
resistance in obese patients with type 2
diabetes. Ann Intern Med. 2005;142(6):
403–11.
[46] Eisenstein J, Roberts SB, Dallal G,
and Saltzman E. High-protein weight-
loss diets: are they safe and do they
work? A review of the experimental and
epidemiologic data. Nutr Rev. 2002;60(7
Pt 1):189–200.
[47] Bray GA, Smith, S.R., de Jonge, L.
Effect of dietary protein content on
weight gain, energy expenditure, and
body composition during overeating: a
14
Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic
randomized controlled trial. JAMA.
2012;307(1):47–55.
[48] Kitabchi AE, Stentz FB,
McDaniel KA, Wan JY, Nyenwe E, and
Sands CW. Effects of high-protein
versus high-carbohydrate diets on
markers of beta-cell function, oxidative
stress, lipid peroxidation,
proinflammatory cytokines, and
adipokines in obese, premenopausal
women without diabetes: a randomized
controlled trial. Diabetes Care. 2013;36
(7):1919–25.
[49] Stentz FB, Brewer A, Wan J,
Garber C, Daniels B, Sands C, and
Kitabchi AE. Remission of pre-diabetes
to normal glucose tolerance in obese
adults with high protein versus high
carbohydrate diet: randomized control
trial. BMJ Open Diabetes Res Care. 2016;4
(1):e000258.
[50] Stentz F, Kimeish, O, Kitabchi, A.
Effect of High Protein vs High
Carbohydrate Diets on Incretins, Satiety
and Cardiovascular Factors. Diabetes.
2014;62: (Suppl 1):1825.
[51] Stentz FB, Ammons, A. , Sands, C.
Incretin and Cardiovascular Effects of
Weight Loss and Remission of
Prediabetes. Diabetes. 2018;67(Suppl 1):
544.
[52]Daniels B, Stentz, FB. Efect of Diet
Composition on Remission of
Prediabetes and Metabolic Parameters. J
Investig Med. 2016;65(2):501.
[53] Fisher FM, Kleiner S, Douris N,
Fox EC, Mepani RJ, Verdeguer F, Wu J,
Kharitonenkov A, Flier JS, Maratos-Flier
E, et al. FGF21 regulates PGC-1alpha
and browning of white adipose tissues in
adaptive thermogenesis. Genes Dev.
2012;26(3):271–81.
[54] Stentz F, Garber, C., Kitabchi, A, .
Efficacy of High Protein vs. High
Carbohydrate Diet on Remission of
Impaired Glucose Tolerance (IGT) to
Normal Glucose Tolerance (NGT).
Diabetes. 2015;64(Supppl 1):512.
[55] Stentz FB, Patel, D. Epigenetic
Changes in DNA Methylation with
Remission of Prediabetes. Diabetes.
2017;66(1):85.
[56]Nuttall FQ, Mooradian AD,
Gannon MC, Billington C, and
Krezowski P. Effect of protein ingestion
on the glucose and insulin response to a
standardized oral glucose load. Diabetes
Care. 1984;7(5):465–70.
[57] Stentz FB, Mikhael, A., Kineish, O,
Christman, J.V, Sands, C. Incretins and
Cardiovascular Effects of Weight Loss
and Remission of Prediabetes. J Diabet
Clin Studies (JDCS). 2020.
[58] American Diabetes Association.
Standard of Medical Care in Diabetes.
Diabetes Care. 2018;41(Suppl 1):S1-S7.
[59] Eng C, Kramer CK, Zinman B, and
Retnakaran R. Glucagon-like peptide-1
receptor agonist and basal insulin
combination treatment for the
management of type 2 diabetes: a
systematic review and meta-analysis.
Lancet. 2014;384(9961):2228–34.
[60] Stentz FB, Tucker, S. , Sands, C.
Remision of Type 2 Diabetes and
Improvement of Metabolic Factors with
a High Protein Diet Diabetes. 2020;
Diabetes website(1862.
[61] Goldin A, Beckman JA,
Schmidt AM, and Creager MA.
Advanced glycation end products:
sparking the development of diabetic
vascular injury. Circulation. 2006;114
(6):597–605.
[62] Vistoli G, De Maddis D, Cipak A,
Zarkovic N, Carini M, and Aldini G.
Advanced glycoxidation and
lipoxidation end products (AGEs and
ALEs): an overview of their mechanisms
of formation. Free Radic Res. 2013;47
Suppl 1(3–27.
15
Hyperglycemia- and Hyperlipidemia-Induced Inflammation and Oxidative Stress…
DOI: http://dx.doi.org/10.5772/intechopen.94427
[63] Chaudhuri J, Bains Y, Guha S,
Kahn A, Hall D, Bose N, Gugliucci A,
and Kapahi P. The Role of Advanced
Glycation End Products in Aging and
Metabolic Diseases: Bridging
Association and Causality. Cell Metab.
2018;28(3):337–52.
[64] Yan SF, D'Agati V, Schmidt AM,
and Ramasamy R. Receptor for
Advanced Glycation Endproducts
(RAGE): a formidable force in the
pathogenesis of the cardiovascular
complications of diabetes & aging. Curr
Mol Med. 2007;7(8):699–710.
[65] BrownleeM. The pathobiology of
diabetic complications: a unifying
mechanism.Diabetes. 2005;54(6):1615–25.
[66] Prasad A, Bekker P, and Tsimikas S.
Advanced glycation end products and
diabetic cardiovascular disease. Cardiol
Rev. 2012;20(4):177–83.
[67] Srikanth V, Maczurek A, Phan T,
Steele M, Westcott B, Juskiw D, and
Munch G. Advanced glycation
endproducts and their receptor RAGE in
Alzheimer's disease. Neurobiol Aging.
2011;32(5):763–77.
[68]Martins IJ. Anti-Aging Genes
Improve Appetite Regulation and
Reverse Cell Senescence and Apoptosis
in Global Populations. Advances in Aging
Research. 2016;5(9–26.
[69]Martins IJ. Single Gene Inactivation
with Implications to Diabetes and
Multiple Organ Dysfunction Symdrome.
J Clin Epigenet. 2017;3(3–24.
[70] Stentz F, Headley, S., Tolley, E.,
Meduri, G.U.,. The Interaction of
Proinflammatory Cytokines (PIC) and
NF-kB in Acute Respiratory Distress
Syndrome (ARDS) and Response to
Treatment with Methylprednisolone




[71]Meduri GU, Tolley EA, Chrousos GP,
and Stentz F. Prolonged
methylprednisolone treatment suppresses
systemic inflammation in patients with
unresolving acute respiratory distress
syndrome: evidence for inadequate
endogenous glucocorticoid secretion and
inflammation-induced immune cell
resistance to glucocorticoids.Am J Respir
Crit CareMed. 2002;165(7):983–91.
[72] Lim S, Won H, Kim Y, Jang M,
Jyothi KR, Dandona P, Ha J, and Kim SS.
Antioxidant enzymes induced by
repeated intake of excess energy in the
form of high-fat, high-carbohydrate
meals are not sufficient to block
oxidative stress in healthy lean
individuals. Br J Nutr. 2011;106(10):
1544–51.
16
Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic
